Skip to content

Clinical study on the application of esketamine in painless gastroenteroscopy anesthesia

Clinical study on the application of esketamine in painless gastroenteroscopy anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100552
Enrollment
Unknown
Registered
2025-04-10
Start date
2022-01-07
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse reactions, hypotension, decreased oxygen saturation and so on were observed by gastroscopy.

Interventions

Group A:Patients in group A were given rapid intravenous induction with esketamine(0.3mg/kg)and propofol(2mg/kg).
Group B:Patients in group A were given rapid intravenous induction with esketamine(0.5mg/kg)and propofol(2mg/kg).

Sponsors

Deyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. the age was 20-45 years old; 2. all races were acceptable; 3. patients needed painless gastroenteroscopy; 4. ASA grade 1-2; 5. patients signed written consent for anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients have serious underlying diseases, such as poorly controlled hypertension, severe ischemic heart disease, congestive heart failure and poor liver and kidney function, kidney disease requiring dialysis, and so on. 2. The patient did not sign the consent form for anesthesia. 3. Those who are allergic to esmolamine or excipients. 4. Patients with severe risk of hypertension or elevated intracranial pressure. 5. patients with severe mental disorders. 6. Patients with hyperthyroidism who are untreated or with poor therapeutic effect. 7. Patients with high intraocular pressure, such as glaucoma. 8. There are patients with drug abuse or dependence.

Design outcomes

Primary

MeasureTime frame
Total consumption of propofol;

Secondary

MeasureTime frame
Vital signs;Induction time?Operation time;Awakening time;MOAA/S one minute after administration;Adverse reaction;Additional amount of propofol is required;Endoscopic physician / anesthesiologist / patient satisfaction;

Countries

China

Contacts

Public ContactJia Han

Deyang People's Hospital

453922152@qq.com+86 838 2418184

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026